Issue 27, 2021

Arylbiamidines: synthesis and structural studies en route to anticancer applications

Abstract

Biamidines are a unique and poorly studied class of nitrogenous compounds prone to tautomerization and H-bonding. Four series of heteroaryl diarylbiamidines were synthesized and the antimelanoma activity and physicochemical properties of the resulting 37 new compounds were evaluated. The dimethylthiazolyl 3-bromophenyl biamidine derivative B6 inhibits the growth of six different melanoma cell lines, having higher activity than the positive control drug, the B-RAF inhibitor PLX4032. This study introduces diarylbiamidines as promising frameworks for drug discovery.

Graphical abstract: Arylbiamidines: synthesis and structural studies en route to anticancer applications

Supplementary files

Article information

Article type
Communication
Submitted
21 Apr 2021
Accepted
19 May 2021
First published
27 May 2021

New J. Chem., 2021,45, 11893-11897

Arylbiamidines: synthesis and structural studies en route to anticancer applications

O. Grytsai, L. C. P. Gonçalves, R. Bardovskyi, N. Hamouda-Tekaya, S. Rocchi, C. Ronco and R. Benhida, New J. Chem., 2021, 45, 11893 DOI: 10.1039/D1NJ01943K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements